Cargando…
Canine Fibroblast Growth Factor 21 Ameliorates Hyperglycemia Associated with Inhibiting Hepatic Gluconeogenesis and Improving Pancreatic Beta-Cell Survival in Diabetic Mice and Dogs
Diabetes mellitus is a common endocrinopathy in dog. Fibroblast growth factor 21 (FGF-21) is a secreted protein, which is involved in glucose homeostasis. We speculate that the recombinant canine FGF-21 (cFGF-21) has the potential to become a powerful therapeutics to treat canine diabetes. The cFGF-...
Autores principales: | Xu, Pengfei, Zhang, Yingjie, Jiang, Xinghao, Li, Junyan, Song, Liying, Khoso, Mir Hasson, Liu, Yunye, Wu, Qiang, Ren, Guiping, Li, Deshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874679/ https://www.ncbi.nlm.nih.gov/pubmed/27203422 http://dx.doi.org/10.1371/journal.pone.0155598 |
Ejemplares similares
-
Fibroblast Growth Factor–21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells
por: Opoku, Yeboah Kwaku, et al.
Publicado: (2020) -
Sodium Meta-Arsenite Ameliorates Hyperglycemia in Obese Diabetic db/db Mice by Inhibition of Hepatic Gluconeogenesis
por: Lee, Young-Sun, et al.
Publicado: (2014) -
α-Ketoglutaric acid ameliorates hyperglycemia in diabetes by inhibiting hepatic gluconeogenesis via serpina1e signaling
por: Yuan, Yexian, et al.
Publicado: (2022) -
Renal gluconeogenesis in insulin resistance: A culprit for hyperglycemia in diabetes
por: Sharma, Rajni, et al.
Publicado: (2021) -
Fibroblast growth factor-21 as a novel metabolic factor for regulating thrombotic homeostasis
por: Li, Shuai, et al.
Publicado: (2022)